Core Viewpoint - Daoshi Technology announced an investment of $30 million in Qiangna Technology to acquire minority shareholder rights, aiming to enhance its capabilities in AI and new materials, particularly in the application of carbon materials in key components like electronic skin [2]. Group 1: Company Overview - Daoshi Technology, established in 2007 and listed in December 2014, focuses on carbon materials, lithium battery materials, and ceramic materials, with key products including graphene conductive agents and carbon nanotube conductive agents [3]. - In the first half of 2025, Daoshi Technology reported revenue of 3.654 billion yuan, a year-on-year decrease of 11.64%, while net profit attributable to shareholders increased by 108.16% to 230 million yuan, with basic earnings per share at 0.32 yuan [3]. Group 2: Investment and Strategic Direction - The investment in Qiangna Technology is part of Daoshi Technology's strategy to leverage Qiangna's expertise in brain-computer interface technology across medical rehabilitation, educational consumption, and human-computer interaction [2]. - Daoshi Technology has been actively developing a collaborative R&D system for "AI + materials" and announced plans to establish a computing center to enhance its research capabilities [3]. Group 3: Qiangna Technology Profile - Qiangna Technology, recognized as one of the "Six Little Dragons of Hangzhou," specializes in non-invasive brain-computer interface technology, with core products including smart bionic hands and legs [2]. - The company has a strong technical barrier and commercialization capability, with over 460 authorized patents and its core products certified by international standards such as FDA and CE [2].
道氏技术子公司拟3000万美元 认购强脑科技Pre-B轮优先股